Clinical trials
Phase 2 Fatty Liver trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 5 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 6 |
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 7 |
| Metacrine, Inc. | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Sagimet Biosciences Inc. | 2 |
| 89bio, Inc. | 1 |
| Abhimanyu Garg | 1 |
| Adrian Vella | 1 |
| Akcea Therapeutics | 1 |
| AstraZeneca | 1 |
| Axcella Health, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 41 |
| Non-alcoholic Fatty Liver Disease | 32 |
| Liver Diseases | 9 |
| Diabetes Mellitus | 8 |
| Fibrosis | 8 |
| Insulin Resistance | 7 |
| Obesity | 6 |
| Diabetes Mellitus, Type 2 | 4 |
| Digestive System Diseases | 4 |
| Liver Cirrhosis | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.